Lorcaserin (APD-356, trgovsko ime po odobritvi Belviq,pričakovano trgovsko ime med razvojem,Lorqess je zdravilo za hujšanje, ki ga je razvilo podjetje Arena Pharmaceuticals. Ima serotonergične lastnosti in deluje kot anoretik. 22 decembra 2009 nova aplikacija za zdravila (NDA) je bil predložen Uradu za hrano in zdravila (FDA) v Združenih državah Amerike.On 16 Septembra 2010 je svetovalni odbor FDA glasoval za zavrnitev odobritve zdravila na podlagi pomislekov glede varnosti in učinkovitosti..
1.Lorcaserin se uporablja z vadbo, ki jo odobri zdravnik,sprememba vedenja,and reduced-calorie diet program to help you lose weight.It is used by certain overweight people,such as those who are obese or have weight-related medical problems.Losing weightand keeping it off can lessen the many health risks that come with obesity,including heart disease,diabetes,high blood pressure,and a shorter life. Lorcaserin belongs to a class of drugs known as serotonin receptor agonists.It is thought to work by affecting a certain part of the brain that helps control your appetite.
2.Lorcaserin is used together with a reduced-calorie diet and proper exercise to help you lose weight.It is also used in overweight people who may also have diabetes,high blood pressure,high cholesterol,or heart disease.
Lorcaserin je zdravilo na recept, ki se uporablja za pomoč odraslim, ki so debeli ali imajo prekomerno telesno težo in imajo zdravstvene težave, povezane s težo, da shujšajo in preprečijo, da bi ponovno pridobili težo. Lorcaserin je treba uporabljati skupaj z dieto z zmanjšanim vnosom kalorij in načrtom vadbe.
